PUBLIC COMPANY
save$INKTMiNK Therapeutics, Inc.
$INKT12.44-2.28%New York, NY, USupdated 2d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
🐶 Hiring Signal
News
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine raceFollowing their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized cancer vaccines. Here are five companies with similar therapies hoping to…biospace · 21d ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that